|
시장보고서
상품코드
1591394
세계의 약물감시 및 의약품 안전성 소프트웨어 시장 : 시장 규모 및 예측, 지역별 점유율, 동향, 성장 기회 분석 보고서 - 제공별, 전개별, 기업 규모별, 형태별, 기능별, 최종 사용자별, 지역별Pharmacovigilance and Drug Safety Software Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering, Deployment, Enterprise Size, Form, Functionality, End User, and Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
약물감시 및 의약품 안전성 소프트웨어 시장 규모는 2023년에 2억 1,439만 달러로 평가되었고, 2031년에는 3억 5,931만 달러에 달할 것으로 예측되며, 2023년부터 2031년까지 CAGR은 6.7% 기록할 것으로 전망됩니다.
약물감시 및 의약품 안전성 소프트웨어 시장은 북미, 유럽, 아시아태평양(APAC), 중동 및 아프리카(MEA), 중남미의 주요 5개 지역으로 구분됩니다. 2023년 시장 규모는 북미가 압도적으로 크고, 이어 유럽, 아시아 태평양 순이었습니다. 북미의 약물감시 및 의약품 안전성 소프트웨어 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 약물감시 및 의약품 안전성 소프트웨어의 발전에 지속적으로 노력하고 있는 IQVIA Oracle 코퍼레이션과 같은 다양한 시장 기업의 존재로 약물감시 및 의약품 안전성 소프트웨어 시장에서 놀라운 성장을 보이고 있습니다. 2024년 7월 오라클 코퍼레이션은 AI 기반 오라클 아구스 플랫폼을 Safety One Intake 솔루션으로 발표했습니다. 이 솔루션은 생명 과학 회사가 확장하는 규제 요구 사항을 충족하고 증가하는 유해 사례를 완화하는 데 도움이 됩니다. 이 새로운 약물감시 플랫폼은 생산성 향상, 데이터 프라이버시 개선, 보고 강화를 목적으로 하고 있습니다. 따라서 이 지역의 시장 기업에 의한 이러한 제품 혁신은 이 지역에서의 약물감시 및 의약품 안전성 소프트웨어 시장의 성장을 촉진하고 있습니다.
아시아태평양은 인도, 중국, 일본, 한국, 호주 및 기타 아시아태평양을 포함한 다양한 성장 경제권으로 구성되어 있습니다. 아시아 태평양 지역에서는 헬스케어 분야의 디지털화가 진행되고 있습니다. 이 지역 정부는 건강 관리 시스템을 강화하고 디지털화하기 위해 다양한 노력을 하고 있습니다. 예를 들어, 중국 공무원 의료비는 2023년 3 185억 달러에 이르렀습니다. 인도 브랜드 자금 재단에 따르면 인도의 건강 관리 산업은 2023년 3,720억 달러로 평가되었으며 공공 부문과 민간 부문 모두가 견인하고 있습니다. 아시아태평양 국가 전체에서 이러한 의료 지출 증가는 예측 기간 동안 약물감시 및 의약품 안전성 소프트웨어 시장의 성장을 위한 대규모 수요를 생산하고 있습니다.
기업 규모에 따라 세계의 약물감시 및 의약품 안전성 소프트웨어 시장은 중소기업과 대기업으로 2분할 됩니다. 대기업의 약물감시 소프트웨어 투자가 증가함에 따라 2023년에는 대기업 부문이 기업 규모별 시장을 독점하고 있습니다. 세계에 사업을 전개하는 대기업은 여러 지역의 약물감시 가이드라인을 준수해야 합니다. 약물감시 소프트웨어는 세계적인 안전성 데이터의 통합과 표준화를 지원해 이들 조직이 여러 지역에서 의약품의 안전성을 실시간으로 모니터링할 수 있도록 합니다. 대규모 조직에서는 임상시험 중 및 시판 후 모두 대량의 유해 사건 데이터를 받습니다. 약물감시 소프트웨어는 이러한 조직이 증가하는 데이터 양을 효율적으로 관리하고 분석하여 컴플라이언스 위반 및 안전 신호를 놓칠 가능성을 줄이는 데 도움이 됩니다. 약물감시 소프트웨어는 기밀성이 높은 환자 데이터를 처리하기 위해 대기업은 유럽의 일반 데이터 보호 규칙(GDPR-EU 개인정보보호규정)과 같은 데이터 보호 규정에 대한 준수를 보장하기 위해 강력한 데이터 보안 및 개인 정보 보호 기능을 갖춘 소프트웨어 솔루션을 채용하고 있습니다.
ArisEurope; ICON plc; Syneos Health; Accenture; IQVIA; Genpact; Cognizant; Paraxel International Corporation; Laboratory Corporation of America Holdings; Max Application; Clinevo Technologies; Qinecsa Solutions; AB Cube; 및 Veeva Systems은 이 시장 조사에서 분석되고 있는 약물감시 및 의약품 안전성 소프트웨어 시장의 주요 기업입니다.
약물감시 및 의약품 안전성 소프트웨어 시장 규모는 1차정보 및 2차정보 모두를 이용하여 산출되고 있습니다. 약물감시 및 의약품 안전성 소프트웨어의 시장 규모에 관련되는 정성적 및 정량적 정보를 얻기 위해 사내외의 출처를 이용하여 철저한 2차 조사를 실시했습니다. 이 프로세스는 모든 시장 부문에 관한 시장의 개요와 예측을 얻는 데도 도움이 됩니다. 또, 데이터를 검증하고 분석적 인사이트를 얻기 위해 업계 관계자들에게 1차 인터뷰를 실시했습니다. 이 프로세스에는 약물감시 및 의약품 안전성 소프트웨어 시장을 전문으로 하는 부사장, 시장 개발 매니저, 시장 인텔리전스 매니저, 국내 영업 매니저 등의 업계 전문가와 평가 전문가, 리서치 애널리스트, 키오피니언 리더 등 외부 컨설턴트가 참여하고 있습니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
- 시장의 매력
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설의 책정
- 거시경제 요인분석
- 기초 수치의 작성
- 데이터의 삼각측량
- 국가 수준 데이터
제4장 약물감시 및 의약품 안전성 소프트웨어 시장 상황
- PEST 분석
- 생태계 분석
- 소프트웨어 및 서비스 제공업체
- 시스템 통합자
- 규제기관
- 최종 사용자
- 밸류체인의 벤더 일람
제5장 약물감시 및 의약품 안전성 소프트웨어 시장-주요 시장 역학
- 약물감시 및 의약품 안전성 소프트웨어 시장-주요 시장 역학
- 시장 성장 촉진요인
- 의약품 부작용 증가
- 약물감시의 세계화
- 의약품 개발비의 급증
- 시장 성장 억제요인
- 높은 설치 비용과 유지 보수 비용
- 시장 기회
- AI, ML, NLP와 소프트웨어의 통합
- 향후의 동향
- 클라우드 기반 파마 코비지런스 및 의약품 안전 소프트웨어
- 성장 촉진요인 및 억제요인의 영향
제6장 약물감시 및 의약품 안전성 소프트웨어 시장 : 세계 시장 분석
- 약물감시 및 의약품 안전성 소프트웨어 시장 수익(2021-2031년)
- 약물감시 및 의약품 안전성 소프트웨어 시장 예측 분석
제7장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 제공별
- 소프트웨어
- 서비스
제8장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 전개별
- 클라우드
- 온프레미스
제9장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 기업 규모별
- 대기업
- 중소기업
제10장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 형태별
- 표준형
- 커스터마이즈
제11장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 기능별
- 시그널 및 리스크 관리
- 문제 추적 및 부작용 추적
- 증례 관리
- 임상 안전성 관리 및 임상시험 안전성
- 품질 및 컴플라이언스
- 메디컬 라이팅
- 감사 지원 및 교육 규정 준수
- 헬스케어 분석
- 기타
제12장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 최종 사용자별
- 제약 및 바이오테크놀러지 기업
- 수탁연구기관
- 비즈니스 프로세스 아웃소싱(BPO) 기업
- 기타
제13장 약물감시 및 의약품 안전성 소프트웨어 시장 분석 : 지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- APAC 기타 국가
- 중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 남아프리카
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제14장 경쟁 구도
- 주요 기업의 히트맵 분석
- 기업의 포지셔닝과 집중도
제15장 업계 정세
- 시장 이니셔티브
- 합병 및 인수
제16장 기업 프로파일
- ArisGlobal LLC
- Max Application
- Oracle Corp
- Veeva Systems Inc
- IQVIA Holdings Inc
- ICON Plc
- Cognizant Technology Solutions Corp
- Accenture Plc
- Syneos Health Inc
- Genpact Ltd.
- AB Cube SAS
- Laboratory Corp of America Holdings
- Parexel International Corp
- Qinecsa Solutions
- Clinevo Technologies
제17장 부록
AJY 24.11.27The pharmacovigilance and drug safety software market size was valued at US$ 214.39 million in 2023 and is expected to reach US$ 359.31 million by 2031; it is estimated to record a CAGR of 6.7% from 2023 to 2031.
The pharmacovigilance and drug safety software market is segmented into five major regions-North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2023, followed by Europe and Asia Pacific, respectively. The pharmacovigilance and drug safety software market in North America is segmented into the US, Canada, and Mexico. North America is witnessing tremendous growth in the pharmacovigilance and drug safety software market, owing to the presence of various market players such as IQVIA Oracle Corporation, who are continuously working on the advancement of pharmacovigilance and drug safety software. In July 2024, Oracle Corporation launched an AI-based Oracle Argus platform as a Safety One Intake solution. This solution helps life science organizations to meet growing regulatory requirements and to mitigate the rising volume of adverse event cases. This new pharmacovigilance platform aimed to increase productivity, improve data privacy, and enhance reporting. Thus, such product innovations by the market players in the region are fueling the growth of the pharmacovigilance and drug safety software market in the area.
Asia Pacific consists of various growing economies such as India, China, Japan, South Korea, Australia, and Rest of Asia Pacific. Asia Pacific is witnessing growing digitization in its healthcare sector. The governments of various countries in the region are taking different initiatives to enhance and digitize the healthcare system. For instance, China's healthcare expenditure of public financial officials reached US$ 318.5 billion in 2023. According to the India Brand Equity Foundation, the Indian Healthcare industry was valued at US$ 372 billion in 2023, driven by both the public and private sectors. Such rising healthcare expenditure across the Asia Pacific countries has created massive demand for the pharmacovigilance and drug safety software market growth during the forecast period.
Based on enterprise size, the global pharmacovigilance and drug safety software market is bifurcated into SMEs and large enterprises. The large enterprises segment dominated the market for enterprise size in 2023 owing to increasing investment by large companies in pharmacovigilance software. Large organizations with global operations must adhere to the pharmacovigilance guidelines of multiple regions. Pharmacovigilance software helps consolidate and standardize global safety data, ensuring that these organizations can monitor drug safety in real time across multiple geographies. Large organizations receive a high volume of adverse event data, both during clinical trials and post-marketing. Pharmacovigilance software helps these organizations manage and analyze the increasing data volume effectively, reducing the chances of noncompliance or missed safety signals. As pharmacovigilance software processes sensitive patient data, large organizations are adopting software solutions with robust data security and privacy features to ensure compliance with data protection regulations such as the General Data Protection Regulation (GDPR) in Europe.
ArisEurope; ICON plc; Syneos Health; Accenture; IQVIA; Genpact; Cognizant; Paraxel International Corporation; Laboratory Corporation of America Holdings; Max Application; Clinevo Technologies; Qinecsa Solutions; AB Cube; and Veeva Systems are among the key pharmacovigilance and drug safety software market players that are profiled in this market study.
The overall pharmacovigilance and drug safety software market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the pharmacovigilance and drug safety software market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the pharmacovigilance and drug safety software market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 Market Attractiveness
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Pharmacovigilance and Drug Safety Software Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Ecosystem Analysis
- 4.3.1 Software/Service Providers:
- 4.3.2 System Integrators:
- 4.3.3 Regulatory Bodies:
- 4.3.4 End-Users:
- 4.3.5 List of Vendors in the Value Chain
5. Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
- 5.1 Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Rise in Incidences of Adverse Drug Reactions
- 5.2.2 Globalization of Pharmacovigilance
- 5.2.3 Surge in Drug Development Spending
- 5.3 Market Restraints
- 5.3.1 High Installation and Maintenance Costs
- 5.4 Market Opportunities
- 5.4.1 Integration of Software with AI, ML, and NLP
- 5.5 Future Trends
- 5.5.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
- 5.6 Impact of Drivers and Restraints:
6. Pharmacovigilance and Drug Safety Software Market - Global Market Analysis
- 6.1 Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021-2031
- 6.2 Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7. Pharmacovigilance and Drug Safety Software Market Analysis - by Offering
- 7.1 Software
- 7.1.1 Overview
- 7.1.2 Software: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Services
- 7.2.1 Overview
- 7.2.2 Services: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
8. Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment
- 8.1 Cloud
- 8.1.1 Overview
- 8.1.2 Cloud: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 On Premises
- 8.2.1 Overview
- 8.2.2 On Premises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
9. Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size
- 9.1 Large Enterprises
- 9.1.1 Overview
- 9.1.2 Large Enterprises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 SMEs
- 9.2.1 Overview
- 9.2.2 SMEs: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
10. Pharmacovigilance and Drug Safety Software Market Analysis - by Form
- 10.1 Standard
- 10.1.1 Overview
- 10.1.2 Standard: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2 Customized
- 10.2.1 Overview
- 10.2.2 Customized: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
11. Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality
- 11.1 Signal and Risk Management
- 11.1.1 Overview
- 11.1.2 Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2 Issue Tracking and Adverse Event Tracking
- 11.2.1 Overview
- 11.2.2 Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.3 Case Management
- 11.3.1 Overview
- 11.3.2 Case Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4 Clinical Safety Management and Clinical Trial Safety
- 11.4.1 Overview
- 11.4.2 Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.5 Quality and Compliance
- 11.5.1 Overview
- 11.5.2 Quality and Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.6 Medical Writing
- 11.6.1 Overview
- 11.6.2 Medical Writing: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.7 Audit Support and Training Compliance
- 11.7.1 Overview
- 11.7.2 Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.8 Healthcare Analytics
- 11.8.1 Overview
- 11.8.2 Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 11.9 Others
- 11.9.1 Overview
- 11.9.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
12. Pharmacovigilance and Drug Safety Software Market Analysis - by End User
- 12.1 Pharmaceutical and Biotechnology Companies
- 12.1.1 Overview
- 12.1.2 Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2 Contract Research Organizations
- 12.2.1 Overview
- 12.2.2 Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3 Business Process Outsourcing (BPO) Firms
- 12.3.1 Overview
- 12.3.2 Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4 Others
- 12.4.1 Overview
- 12.4.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
13. Pharmacovigilance and Drug Safety Software Market - Geographical Analysis
- 13.1 Overview
- 13.2 North America
- 13.2.1 North America Pharmacovigilance and Drug Safety Software Market Overview
- 13.2.2 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.3 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.2.3.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
- 13.2.4 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.2.4.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
- 13.2.5 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.2.5.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
- 13.2.6 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.2.6.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
- 13.2.7 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.2.7.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
- 13.2.8 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.2.8.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
- 13.2.9 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.2.9.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.2.9.2 United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.9.2.1 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.2.9.2.2 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.2.9.2.3 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.2.9.2.4 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.2.9.2.5 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.2.9.2.6 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.2.9.3 Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.9.3.1 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.2.9.3.2 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.2.9.3.3 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.2.9.3.4 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.2.9.3.5 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.2.9.3.6 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.2.9.4 Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.2.9.4.1 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.2.9.4.2 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.2.9.4.3 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.2.9.4.4 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.2.9.4.5 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.2.9.4.6 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3 Europe
- 13.3.1 Europe Pharmacovigilance and Drug Safety Software Market Overview
- 13.3.2 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.3 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.3.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
- 13.3.4 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.4.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
- 13.3.5 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.5.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
- 13.3.6 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.6.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
- 13.3.7 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.7.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
- 13.3.8 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.8.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
- 13.3.9 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.3.9.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.3.9.2 Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.2.1 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.2.2 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.2.3 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.2.4 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.2.5 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.2.6 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.9.3 France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.3.1 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.3.2 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.3.3 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.3.4 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.3.5 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.3.6 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.9.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.4.1 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.4.2 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.4.3 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.4.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.4.5 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.4.6 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.9.5 Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.5.1 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.5.2 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.5.3 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.5.4 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.5.5 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.5.6 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.9.6 Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.6.1 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.6.2 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.6.3 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.6.4 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.6.5 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.6.6 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.3.9.7 Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.3.9.7.1 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.3.9.7.2 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.3.9.7.3 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.3.9.7.4 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.3.9.7.5 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.3.9.7.6 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4 Asia Pacific
- 13.4.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview
- 13.4.2 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.3 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.3.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
- 13.4.4 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.4.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
- 13.4.5 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.5.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
- 13.4.6 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.6.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
- 13.4.7 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.7.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
- 13.4.8 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.8.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
- 13.4.9 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.4.9.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.4.9.2 China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.2.1 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.2.2 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.2.3 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.2.4 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.2.5 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.2.6 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.9.3 Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.3.1 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.3.2 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.3.3 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.3.4 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.3.5 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.3.6 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.9.4 India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.4.1 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.4.2 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.4.3 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.4.4 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.4.5 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.4.6 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.9.5 South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.5.1 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.5.2 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.5.3 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.5.4 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.5.5 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.5.6 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.9.6 Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.6.1 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.6.2 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.6.3 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.6.4 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.6.5 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.6.6 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.4.9.7 Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.4.9.7.1 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.4.9.7.2 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.4.9.7.3 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.4.9.7.4 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.4.9.7.5 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.4.9.7.6 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.5 Middle East and Africa
- 13.5.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Overview
- 13.5.2 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.3 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.5.3.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
- 13.5.4 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.5.4.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
- 13.5.5 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.5.5.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
- 13.5.6 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.5.6.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
- 13.5.7 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.5.7.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
- 13.5.8 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.5.8.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
- 13.5.9 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.5.9.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.5.9.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.9.2.1 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.5.9.2.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.5.9.2.3 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.5.9.2.4 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.5.9.2.5 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.5.9.2.6 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.5.9.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.9.3.1 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.5.9.3.2 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.5.9.3.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.5.9.3.4 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.5.9.3.5 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.5.9.3.6 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.5.9.4 South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.9.4.1 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.5.9.4.2 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.5.9.4.3 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.5.9.4.4 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.5.9.4.5 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.5.9.4.6 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.5.9.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.5.9.5.1 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.5.9.5.2 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.5.9.5.3 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.5.9.5.4 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.5.9.5.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.5.9.5.6 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.6 South and Central America
- 13.6.1 South and Central America Pharmacovigilance and Drug Safety Software Market Overview
- 13.6.2 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.3 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.6.3.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
- 13.6.4 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.6.4.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
- 13.6.5 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.6.5.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
- 13.6.6 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.6.6.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
- 13.6.7 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.6.7.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
- 13.6.8 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.6.8.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
- 13.6.9 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.6.9.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
- 13.6.9.2 Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.9.2.1 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.6.9.2.2 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.6.9.2.3 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.6.9.2.4 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.6.9.2.5 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.6.9.2.6 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.6.9.3 Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.9.3.1 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.6.9.3.2 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.6.9.3.3 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.6.9.3.4 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.6.9.3.5 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.6.9.3.6 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 13.6.9.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
- 13.6.9.4.1 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 13.6.9.4.2 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 13.6.9.4.3 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 13.6.9.4.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 13.6.9.4.5 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
- 13.6.9.4.6 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
14. Competitive Landscape
- 14.1 Heat Map Analysis by Key Players
- 14.2 Company Positioning & Concentration
15. Industry Landscape
- 15.1 Overview
- 15.2 Market Initiative
- 15.3 Merger and Acquisition
16. Company Profiles
- 16.1 ArisGlobal LLC
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
- 16.2 Max Application
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
- 16.3 Oracle Corp
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
- 16.4 Veeva Systems Inc
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
- 16.5 IQVIA Holdings Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
- 16.6 ICON Plc
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
- 16.7 Cognizant Technology Solutions Corp
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
- 16.8 Accenture Plc
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
- 16.9 Syneos Health Inc
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
- 16.10 Genpact Ltd.
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
- 16.11 AB Cube S.A.S.
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
- 16.12 Laboratory Corp of America Holdings
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments
- 16.13 Parexel International Corp
- 16.13.1 Key Facts
- 16.13.2 Business Description
- 16.13.3 Products and Services
- 16.13.4 Financial Overview
- 16.13.5 SWOT Analysis
- 16.13.6 Key Developments
- 16.14 Qinecsa Solutions
- 16.14.1 Key Facts
- 16.14.2 Business Description
- 16.14.3 Products and Services
- 16.14.4 Financial Overview
- 16.14.5 SWOT Analysis
- 16.14.6 Key Developments
- 16.15 Clinevo Technologies
- 16.15.1 Key Facts
- 16.15.2 Business Descri
- 16.15.3 Products and Services
- 16.15.4 Financial Overview
- 16.15.5 SWOT Analysis
- 16.15.6 Key Developments
17. Appendix
- 17.1 Word Index
- 17.2 About the Insight Partners
비교리스트